173 related articles for article (PubMed ID: 35893047)
1. Genetic and Phenotypic Factors Affecting Glycemic Response to Metformin Therapy in Patients with Type 2 Diabetes Mellitus.
Nasykhova YA; Barbitoff YA; Tonyan ZN; Danilova MM; Nevzorov IA; Komandresova TM; Mikhailova AA; Vasilieva TV; Glavnova OB; Yarmolinskaya MI; Sluchanko EI; Glotov AS
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893047
[TBL] [Abstract][Full Text] [Related]
2. Altered Glycemic Control Associated With Polymorphisms in the SLC22A1 (OCT1) Gene in a Mexican Population With Type 2 Diabetes Mellitus Treated With Metformin: A Cohort Study.
Reséndiz-Abarca CA; Flores-Alfaro E; Suárez-Sánchez F; Cruz M; Valladares-Salgado A; Del Carmen Alarcón-Romero L; Vázquez-Moreno MA; Wacher-Rodarte NA; Gómez-Zamudio JH
J Clin Pharmacol; 2019 Oct; 59(10):1384-1390. PubMed ID: 31012983
[TBL] [Abstract][Full Text] [Related]
3. A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetes.
Rathmann W; Strassburger K; Bongaerts B; Kuss O; Müssig K; Burkart V; Szendroedi J; Kotzka J; Knebel B; Al-Hasani H; Roden M;
Diabetologia; 2019 Feb; 62(2):286-291. PubMed ID: 30413829
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of the SLC47A1 and SLC47A2 gene polymorphisms on the glycemic response to metformin in type 2 diabetes mellitus patients.
Raj GM; Mathaiyan J; Wyawahare M; Priyadarshini R
Drug Metab Pers Ther; 2018 Dec; 33(4):175-185. PubMed ID: 30433870
[TBL] [Abstract][Full Text] [Related]
5. Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus.
Pérez-Gómez N; Fernández-Ortega MD; Elizari-Roncal M; Santos-Mazo E; la Maza-Pereg L; Calvo S; Alcaraz R; Sanz-Solas A; Vinuesa R; Saiz-Rodríguez M
Pharmacogenomics; 2023 Aug; 24(12):651-663. PubMed ID: 37610884
[TBL] [Abstract][Full Text] [Related]
6. Influence of SLC22A1 rs622342 genetic polymorphism on metformin response in South Indian type 2 diabetes mellitus patients.
Umamaheswaran G; Praveen RG; Damodaran SE; Das AK; Adithan C
Clin Exp Med; 2015 Nov; 15(4):511-7. PubMed ID: 25492374
[TBL] [Abstract][Full Text] [Related]
7. Clinical Study on the Relationship between the SNP rs8192675 (C/C) Site of SLC2A2 Gene and the Hypoglycemic Effect of Metformin in Type 2 Diabetes.
Ye W; Wang Y; Chen F; Zhao Q; Meng X; Chen J; Liu C; Zhou Y
J Healthc Eng; 2022; 2022():3645336. PubMed ID: 35140900
[TBL] [Abstract][Full Text] [Related]
8. The influence of metformin transporter gene SLC22A1 and SLC47A1 variants on steady-state pharmacokinetics and glycemic response.
Ningrum VDA; Sadewa AH; Ikawati Z; Yuliwulandari R; Ikhsan MR; Fajriyah R
PLoS One; 2022; 17(7):e0271410. PubMed ID: 35905099
[TBL] [Abstract][Full Text] [Related]
9. Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis.
Peng A; Gong C; Xu Y; Liang X; Chen X; Hong W; Yan J
Front Public Health; 2023; 11():1183879. PubMed ID: 37546319
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of organic cation transporter 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes: A systematic review.
Mofo Mato EP; Guewo-Fokeng M; Essop MF; Owira PMO
Medicine (Baltimore); 2018 Jul; 97(27):e11349. PubMed ID: 29979413
[TBL] [Abstract][Full Text] [Related]
11. [Clinical aspects of the effectiveness of metformin therapy in combination with a low-calorie diet in patients with type 2 diabetes mellitus with various variants of the
Kondratyeva OV; Sharafetdinov KK; Plotnikova OA; Pilipenko VV; Alekseeva RI; Sorokina EY; Peskova EV
Vopr Pitan; 2022; 91(2):5-14. PubMed ID: 35596630
[TBL] [Abstract][Full Text] [Related]
12. Association of SLC22A1 rs622342 and ATM rs11212617 polymorphisms with metformin efficacy in patients with type 2 diabetes.
Chen P; Cao Y; Guo Y; Xu Q; Wang X; Zhang L; Liu Z; Chen D; Chen S; Chen S
Pharmacogenet Genomics; 2022 Feb; 32(2):67-71. PubMed ID: 34545025
[TBL] [Abstract][Full Text] [Related]
13. A Protocol for the Study of Polymorphisms and Response to Metformin in Patients with Type 2 Diabetes in Trinidad.
Clement Y; Singh S; Motilal S; Maharaj R; Nunez-Smith M
Ethn Dis; 2020; 30(Suppl 1):211-216. PubMed ID: 32269463
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants of OCT1 influence glycemic response to metformin in Han Chinese patients with type-2 diabetes mellitus in Shanghai.
Zhou Y; Ye W; Wang Y; Jiang Z; Meng X; Xiao Q; Zhao Q; Yan J
Int J Clin Exp Pathol; 2015; 8(8):9533-42. PubMed ID: 26464716
[TBL] [Abstract][Full Text] [Related]
15. SLC22A2 gene 808 G/T variant is related to plasma lactate concentration in Chinese type 2 diabetics treated with metformin.
Li Q; Liu F; Zheng TS; Tang JL; Lu HJ; Jia WP
Acta Pharmacol Sin; 2010 Feb; 31(2):184-90. PubMed ID: 20139901
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes.
Tkáč I; Klimčáková L; Javorský M; Fabianová M; Schroner Z; Hermanová H; Babjaková E; Tkáčová R
Diabetes Obes Metab; 2013 Feb; 15(2):189-91. PubMed ID: 22882994
[TBL] [Abstract][Full Text] [Related]
17. The pharmacogenetics of type 2 diabetes: a systematic review.
Maruthur NM; Gribble MO; Bennett WL; Bolen S; Wilson LM; Balakrishnan P; Sahu A; Bass E; Kao WH; Clark JM
Diabetes Care; 2014; 37(3):876-86. PubMed ID: 24558078
[TBL] [Abstract][Full Text] [Related]
18. Effects of TCF7L2 rs7903146 variant on metformin response in patients with type 2 diabetes.
Dujic T; Bego T; Malenica M; Velija-Asimi Z; Ahlqvist E; Groop L; Pearson ER; Causevic A; Semiz S
Bosn J Basic Med Sci; 2019 Nov; 19(4):368-374. PubMed ID: 31070566
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus: a systematic review protocol.
Mato EPM; Guewo-Fokeng M; Faadiel Essop M; Owira PMO
Syst Rev; 2018 Jul; 7(1):105. PubMed ID: 30041690
[TBL] [Abstract][Full Text] [Related]
20. Implications of genetic variations, differential gene expression, and allele-specific expression on metformin response in drug-naïve type 2 diabetes.
Vohra M; Sharma AR; Mallya S; Prabhu NB; Jayaram P; Nagri SK; Umakanth S; Rai PS
J Endocrinol Invest; 2023 Jun; 46(6):1205-1218. PubMed ID: 36528847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
